The clinical use of desktop analyzers for lipid and lipoprotein measurements has markedly increased over the past decade. Advantages include increased convenience to patients because the physician can obtain laboratory results during the patient's visit and use only small quantities of venous or fingerstick blood specimens. Disadvantages include the inherent increase in variability associated with desktop analyzers compared with standardized laboratory methods [1-3J and, in some cases, the lack of adequate quality-control procedures within the physician's office.
Assay variation arises from both analytical and biological sources. Overall biological variation within a given population includes among-individual differencesand within-individual variations thatoccur when an individualissampled on several
occasions.
For lipidsand lipoproteins, the within-individual component of biological variance accounts for as much as 20-50% of the overall biological variance, depending on the analyte [4] . The contribution of the within-individual component of biological variance to the overall assay variance of lipid and lipoprotein measurements in serial samples from the same individual is three to five times higher than the contribution of analytical variance [5, 6] . On average, the biological component of variation (CV1,) is 6-7% for total cholesterol (TC) [5] , 24% for triglycerides (TG) [6] , 7-8% for high-density lipoprotein cholesterol (HDL-C) [6] , and 8% for low-density lipoprotein cholesterol (LDL-C) [ 
6].
In -10% of individuals, biological variation can be considerably higher [7, 8] .
In general, greater variation in lipid values is observed in capillary than in venous samples /9], but whether this is entirely attributable to greater analytical variation is not certain. In the present study, we used a desktop analyzer to measure the biological variation of TC, TG, HDL-C, and estimated LDL-C [JO] in venous and capillary specimens from the same subjects. were instructed to maintain their current nutritional intake, exercise program (if any), and smoking status throughout the duration of the study. After the baseline visit, serial venous and fingerstick blood specimens were obtained monthly for three consecutive months from all subjects. At each visit, subjects were asked to complete a new medical history form tabulating any change in concomitant medication, a 24-h dietary recall to assess stability in nutritional intake, and an exercise questionnaire to assess stability in exercise patterns. Enrollment of subjects and sample collection overall took 7 months. respectively) and the removal of excess Mn2 + by precipitation with NaHCO3 as previously described [12] . Each venous sample was analyzed once with the laboratory's methods. The laboratory is standardized for TC, TG, and HDL-C measurement according to the criteria of the Centers for Disease Control and Prevention (CDC)-National Heart, Lung, and Blood Institute Lipid Standardization
Matenals and Methods
Program [13] .
Quality control. Laboratory bias and imprecision during the period of the study were assessed through the analysis of bench control pools furnished by the CDC (Atlanta, GA). Two pools were used for TC and TG (Ql7, Q20) and one pool was used for HDL-C (AQ14). The values assigned to the pools had been determined by the CDC, using CDC Reference Methods. We calculated referencevaluesforLDL-C at two concentrationsby using the CDC referencevalues for pool pairs(Ql7, AQI4; Q20, AQ14). Laboratory biasand imprecisionwith respectto CDC referencevalues are shown in Table I . The laboratory biases averaged -1.5%, -0.1%, +4.0%, and -3.7%
for TC, TG, HDL-C, and LDL-C, respectively.
Statistical analyses. For a given analyte, the CV1, for each subject was calculated from the within-subject variances of the three serial measurements in that subject: The proportion of Var, (i.e., the total within-subject variance) that was accounted for by analytical variance, Var,, was calculated as PropVar., (= Var/Var).
The individual withinsubject biological variance was then calculated as:
Var,, = Var,, -(PropVar., X Var,,) and CV,, was calculated as (Var,,)"2/subject mean. The significance of the differences between venous and fingerstick samples was calculated by using paired t-tests or Mann-\Vhitney rank sum tests.
Resufts
Study subjects. A total of 110 subjects were enrolled into the study. Of these, 10 subjects withdrew from the study because of inability to meet the serial blood sampling requirements. Data from another 17 subjects were not included in the final analyses because (a) TC, TG, or HDL-C measurements were not available for one or more of the three visits (the serum lipid or lipoprotein concentrations were above or below the analytical range of the desktop analyzer); or (b) the TG concentration exceeded 4.0 g/L on any of the three occasions, prohibiting the calculation of LDL-C [JQ/. The final study population used for the analyses thus comprised 83 subjects: 66 women and 27 men. Of these, 60 were Caucasian, 15 African-American, and 8 Asian.
Characteristics of the study subjects are tabulated in Table 2 . Eight subjects had well-controlled hypertension, one subject had glucose intolerance, and four subjects had hypothyroidism and were receiving chronic replacement therapy. Stable concomitant medications included Premarin (n = 4), Relafen (n = 8), Synthroid (n = 4), and birth control pills (n = 7). During the study period, the mean (SD) change in the subjects' weight was -0.7 (2.8)kg (range,-12.3 to 5.2 kg), which was not significant.
Measurements
in serum pools. To estimate CV1, for lipid and lipoprotein concentrations in serialsamples, we first had to determine the CVa for the respective analytes. Repetitive measurements were made in serum pools at two concentrations of each analyte. Aliquots of the two pools were analyzed with both the laboratory and the desktop analyzer methods. The CV, values (Table 3) were generally greater for the desktop analyzer than for the laboratory methods, although for HDL-C the CV,s were similar: 6% by the desktop analyzer and 5% by the laboratory methods.
Biological variation in fingersiick
and venous samples. samples. This finding was predictable, because normal biologianalyzer measurements for HDL-C and LDL-C tended to be cal variation is independent of the methods used for measureslightly higher than the laboratory measurements, but the ment. For LDL-C or HDL-C, differences in Varb were not differences were not statistically significant. significant; for TC and TG, however, they were (P = 0.011 and 0.031, respectively), although the estimates of CVh themselves Desktop analyzer finger:ctick measurements vs laboratory venous were similar by either the laboratory or desktop analyzer assays measurements. The desktop analyzer methods were calibrated by of venous samples (Table 4) .
the manufacturer for use with either whole-blood samples or Estimates of bias between the desktop analyzer and laboraheparinized plasma. The instrument is easily set for either tory methods were determined for all analytes by assaying calibration by changing one switch. In the present study, we set quality-control pools. Measurements made with the desktop the instrument for use with whole blood. This was done for two analyzer exhibited positive bias for all analytes in comparison reasons: first, to determine the bias that would actually occur if with the laboratory measurements. The bias averaged 5% for a single calibration point were used, and second, to eliminate TC, 16% for TG, and 6% for HDL-C (P <0.001 for all three).
possible technical errors of inadvertently using the wrong Because all three measurements were positively biased, the bias calibration set-point for a given specimen. The manufacturer for LDL-C was relatively small, + 1.1% for the low-concentraprovided us with the calibration factors necessary to convert tion pool (P = 0.019) and +3.7% for the high-concentration venous TC, TG, and HDL-C values to equivalent fingerstick pool (P <0.0001).
values. Use of these factors reduced the observed venous values
by 1% for TC, by 6.5% for TG, and by 3.5% for HDL-C. Table 5 When we applied the calibration factors to the mean values for compares the results of the desktop analyzer and laboratory the venous samples from the study subjects (Table 5) , the bias measurements for venous samples. As was observed for the with respect to the laboratory method was reduced by 1% for measurements of control pools (Table 3) , the desktop analyzer TC, by 8.1% for TG, and by 5.8% for HDL-C. measurements for TC and TG in venous samples were higher
Desktop analyzer vs laboratory methods for venous samples.
In assessment of bias between the laboratory-measured yethan the laboratory measurements. The bias for TC was 8% nous concentrations and the desktop analyzer measurements in (P = 0.01); for TG, it was 23% (P = 0.007). The desktop fingerstick samples (data not shown), fingerstick TG values were 12.4% higher than the laboratory venous measurement (P = 0.04 1). The corresponding biases for TC, HDL-C, and TG were all <2%, and none was statistically significant.
Finally, to estimate the actual bias of the desktop analyzer method, we had to account for the bias of the laboratory measurements with respect to CDC Reference Methods. The average laboratory bias for the measured analytes is shown in Table I . Table 6 shows the actual bias of the desktop analyzer measurements after accounting for laboratory bias. For all analytes except TG, the actual bias for the fingerstick samples was considerably less than the bias for the venous samples or for the quality-control serum pools. The CV1, for lipids and lipoproteins has been estimated primarily from measurements in venous samples. Results from a previous study using a desktop analyzer suggested that capillary measurements might be more variable than venous measurements [1] . However, that study examined the total variation observed in single, rather than serial, venous and fingerstick samples and did not allow differentiation between biological and analytical variation.
In the present study, the biological and analytical variability of capillary vs venous specimens was investigated in three serial (monthly) capillary and venous samples obtained from 83 subjects over an average period of 28 weeks. To our knowledge, this is the first such study in fingerstick samples.
There were no significant differences in the biological variations observed in capillary compared with those in venous blood. As expected, the estimates of biological variation in venous samples were similar, regardless of whether the measurements were made with the desktop analyzer or laboratory methods. Thus, from the standpoint of biological variation, lipid and lipoprotein concentrations can be analyzed in either venous or capillary specimens.
With respect to analytical variation, however, desktop analyzer measurements of venous samples were significantly more variable than laboratory measurements, as reflected by analyses of quality-control pools. This was particularly true for TC and LDL-C, for which the CV,, for either in the desktop method was about twice that of the laboratory measurements. Despite the higher analytical variability with the desktop method, however, the CV,, for any of the analytes measured was not excessive for clinical purposes. The method was sufficiently reproducible to permit comparisons of biological variability in capillary and venous specimens.
There were no statistically significant biases for TC, HDL-C, or LDL-C in capillary specimens measured in the desktop analyzer compared with venous samples measured in the laboratory. For TG, the 12% increase in concentration measured by the desktop analyzer over that measured in the laboratory was statistically significant. Desktop analyzer measurements in venous samples and control pools, however, exhibited positive biases with respect to TC, TG, and HDL-C. Thus, capillary (fingerstick) specimens appear to be more nearly accurate or, at least, have less bias (in comparison with CDC reference values) than venous samples measured with the Cholestech desktop analyzer.
The clinical usefulness of desktop analyzer measurements depends on the accuracy and imprecision of the method and on the user's understanding of the inherent limitations in currently available desktop analyzers. The total error of the estimate of a patient's usual concentration of lipids or lipoprotein cholesterol is affected by the analytical variability and inherent bias of the method, and can be estimated by the following equation:
Total error = absolute % bias + (1.96 X CV.,)
The National Cholesterol Education Program (NCEP) guidelines for lipid and lipoprotein measurement specify an acceptable upper limit of total error for TC, TG, HDL-C, and LDL-C ( Table 7) . The Cholestech desktop analyzer meets the NCEP guideline criteria for HDL-C; issues of bias and (or) analytical variability affect the total error for the remaining analytes. Bias can generally be addressed through adjustments in calibration.
It remains to be seen whether improvements in desktop analyzer technology can reduce imprecision to the degree currently obtainable with standardized laboratory measurements. "Laboratory biases used for these calculations are shown in Table 1 .
"Based on the desktop analyzer values shown in Table 3 for each analyte, as determined from 79 analyses of each of two serum pools.
"Based on the data in Table 5 . Actual % biases are from Table 6 and average CV,, for each analyte are from Table 3 .
bsource: [5, 6] .
In summary, we found the biological variations of TC, TG, HDL-C, and LDL-C to be the same in capillary (fingerstick) and venous specimens. The NCEP recommendations for the number of serial specimens required to establish a patient's usual lipid or lipoprotein concentrations [5, 6] were derived from estimates of CVb in venous specimens; however, our data suggest that these criteria can be applied equally to measurements in fingerstick specimens.
